Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 3/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.34 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6878971 | 0.87 | CHRNA7 (0.45) | CHRNA7ALDH1A1BLMMAPTPOLB | |
| SCHEMBL7703033 | 0.84 | CHRNA7 (0.40) | CHRNA7ALDH1A1BLMCHRNB2CHRNA4 | |
| SCHEMBL6875100 | 0.84 | CHRNA7 (0.49) | CHRNA7CHRNB2CHRNA4 | |
| SCHEMBL6882524 | 0.83 | CHRNA7 (0.47) | CHRNA7ALDH1A1POLBMEN1KMT2A | |
| SCHEMBL6884636 | 0.80 | CHRNA7 (0.49) | CHRNA7CHRNB2CHRNA4 | |
| SCHEMBL6883155 | 0.80 | CHRNA7 (0.47) | CHRNA7ALDH1A1CHRNB2CHRNA4MAPT | |
| SCHEMBL6882840 | 0.79 | CHRNA7 (0.49) | CHRNA7ALDH1A1CHRNB2CHRNA4LMNA | |
| SCHEMBL6872595 | 0.79 | CHRNA7 (0.48) | CHRNA7CHRNB2CHRNA4 | |
| SCHEMBL6879586 | 0.79 | CHRNA7 (0.41) | CHRNA7ALDH1A1CHRNB2CHRNA4 | |
| SCHEMBL6881020 | 0.79 | CHRNA7 (0.42) | CHRNA7CHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6486172-B2 | ADMINISTERING TO A MAMMAL A THERAPEUTICALLY EFFECTIVE AMOUNT OF BENZAMIDE OR BENZOCARBONYLSULFIDE SUBSTITUTED 1-AZABICYCLO(2,2,2)OCT-3-YL COMPOUNDS TO TREAT THE CONDITIONS ASSOCIATED WITH DEFECTS OF NICOTINIC SUBTYPES BRAIN RECEPTORS | PHARMACIA & UPJOHN COMPANY | 2002-11-26 | — | — | US | claimed |
| WO-2002016357-A2 | QUINUCLIDINE-SUBSTITUTED ARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS) | PHARMACIA & UPJOHN COMPANY (US) | 2002-02-28 | — | — | WO | claimed |